Intraocular Pressure in Children With Acute Lymphoblastic Leukemia (ALL) Treated With High Dose Steroids

NCT04593745 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-10-22

No results posted yet for this study

Summary

Childhood ALL patients are treated with high dose steroids. The study will follow the intraocular pressure of children treated in according to an AIEOP-BFM protocol, during the induction phase that will be compared to the pressure before treatment. Potential risk factors for developing elevated intraocular pressure will be estimated.

Conditions

  • ALL, Childhood
  • Steroid-Induced Glaucoma

Interventions

DEVICE

Intraocular pressure measurment

Intraocular pressure measurmentt using iCare devise: TONOPEN

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Shlomi Barzilai Birenboim · Schneider Children's Medical Hospital

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Month
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-09
Primary Completion
2023-06-30
Completion
2024-07-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04593745 on ClinicalTrials.gov